| Trial ID: | L0089 |
| Source ID: | NCT03511365
|
| Associated Drug: |
VSL#3
|
| Title: |
Effects of Probiotic on Inflammation and Microbiota in Patients With NASH
|
| Acronym: |
NASHPro
|
| Status: |
Terminated
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease|Probiotics MeSH Descriptor Data 2018|Interleukin-17 MeSH Descriptor Data 2018
|
| Interventions: |
Biological: Probiotic Formulation VSL#3
|
| Outcome Measures: |
Change in Il-17 levels with probiotic administration
|
| Sponsor/Collaborators: |
Northwell Health
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 1/Phase 2
|
| Enrollment: |
6
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science
|
| Start Date: |
May 15, 2018
|
| Completion Date: |
October 11, 2019
|
| Results First Posted: |
--
|
| Last Update Posted: |
January 7, 2020
|
| Locations: |
Northwell Health, Manhasset, New York, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT03511365
|
